Baird Financial Group’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-64,155
| Closed | -$586K | – | 1866 |
|
|
2021
Q4 | $586K | Buy |
64,155
+5,820
| +10% | +$53.2K | ﹤0.01% | 1414 |
|
|
2021
Q3 | $624K | Buy |
58,335
+11,527
| +25% | +$123K | ﹤0.01% | 1389 |
|
|
2021
Q2 | $726K | Buy |
+46,808
| New | +$726K | ﹤0.01% | 1299 |
|
|
2020
Q2 | – | Sell |
-11,517
| Closed | -$135K | – | 1536 |
|
|
2020
Q1 | $135K | Buy |
11,517
+2,140
| +23% | +$25.1K | ﹤0.01% | 1360 |
|
|
2019
Q4 | $220K | Buy |
+9,377
| New | +$220K | ﹤0.01% | 1439 |
|